Search results for "Coronary Vessel"

showing 10 items of 112 documents

Involvement of PKC and NF-κB in Nitric Oxide Induced Apoptosis in Human Coronary Artery Smooth Muscle Cells

2001

Apoptosis of vascular smooth muscle cells is critically involved in progression of atherosclerosis and may prevent intimal hyperplasia in restenosis and vascular remodeling. Nitric oxide (NO) is known to induce apoptosis, but the signaling pathways still remain unclear. We investigated p53 accumulation, protein kinase C (PKC) activation and nuclear transcription factor (NF-kappaB) binding activity as possible signaling mechanisms of NO-induced apoptosis. Apoptosis was induced dose-dependently with the NO-donors sodiumnitroprusside (SNP: 232+/-48%) and SIN-1 (241+/-90% of actinomycin D induced apoptosis; means +/- SEM, *por =0.05 vs. control) in HSMC. Inhibition of PKC significantly attenuat…

Nitroprussidemedicine.medical_specialtyVascular smooth muscleIntimal hyperplasiaPhysiologyApoptosisDNA FragmentationNaphthalenesNitric OxideMuscle Smooth VascularNitric oxidechemistry.chemical_compoundNF-KappaB Inhibitor alphaRestenosisInternal medicinemedicineHumansNitric Oxide DonorsEnzyme InhibitorsCells CulturedProtein Kinase CProtein kinase CCell Nucleusbusiness.industryNF-kappa BNF-κBStaurosporinemedicine.diseaseCoronary VesselsDNA-Binding Proteinsmedicine.anatomical_structurechemistryApoptosisMolsidomineCancer researchCardiologyI-kappa B ProteinsTumor Suppressor Protein p53businessArteryCellular Physiology and Biochemistry
researchProduct

Infarct Size Measurement by Triphenyltetrazolium Chloride StainingVersus In VivoInjection of Propidium Iodide

1997

Infarct size delineation by triphenyltetrazolium chloride (TTC) staining is dependent on sufficient reperfusion. We therefore evaluated the possibility of using propidium iodide (PI), a reagent conventionally used in flow cytometry to fluorescently stain dead cells, for infarct size analysis after short periods of reperfusion. Forty-five rabbits were subjected to either 15 min, 2 h or 4.5 h of coronary artery occlusion without reperfusion, or to 15 min, 30 min and 2 h of coronary artery occlusion followed by 30 min, 1 h and 3 h of reperfusion. Fifteen min before terminating the experiment, PI was injected into the left atrium. Patent blue violet was used to delineate the area at risk. Follo…

Pathologymedicine.medical_specialtyCell Membrane PermeabilityMyocardial InfarctionTetrazolium SaltsMyocardial ReperfusionStainFlow cytometrychemistry.chemical_compoundIn vivoOcclusionmedicineAnimalscardiovascular diseasesPropidium iodideColoring AgentsMolecular BiologyStaining and Labelingmedicine.diagnostic_testChemistrybusiness.industryMyocardiumHistologymedicine.diseaseCoronary VesselsStainingInjections Intra-ArterialRabbitsCardiology and Cardiovascular MedicineNuclear medicinebusinessReperfusion injuryPropidiumJournal of Molecular and Cellular Cardiology
researchProduct

Differences in Symptomatology and Clinical Course of Acute Coronary Syndromes in Women ≤45 Years of Age Compared to Older Women

2021

Acute coronary syndromes (ACS) in young people are rare. The data regarding differences in symptoms in relation to age are scarce, which may have an influence on outcomes. The aim of this study was to evaluate the differences in the clinical course of ACS between younger women (≤45 years old) and older women (63-64 years old). We compared 7481 women with ACS from the Polish Registry of ACS between 2007 and 2014 (1834 women aged ≤45 years and 5647 women aged 63-64 years). The predominant symptom of ACS in both groups was chest pain, with a higher incidence occurring in younger women (90.4% vs 88.5%, P = 0.025). Prehospital cardiac arrest occurred more often in younger women (2.1% vs 0.8%, P0…

Pediatricsmedicine.medical_specialtyAdolescentMEDLINE030204 cardiovascular system & hematologyChest pain03 medical and health sciencesPercutaneous Coronary Intervention0302 clinical medicinemedicineHumans030212 general & internal medicineAcute Coronary SyndromeAgedbusiness.industryIncidence (epidemiology)Age FactorsClinical courseGeneral MedicineMiddle AgedCoronary VesselsTreatment OutcomeST Elevation Myocardial InfarctionFemalemedicine.symptomCardiology and Cardiovascular MedicinebusinessCurrent Problems in Cardiology
researchProduct

Complement and Atherogenesis

1999

Abstract —Complement activation occurs in temporal correlation with the subendothelial deposition of LDL during early atherogenesis, and complement also plays a pathogenetic role in promoting lesion progression. Two lesion components have been identified that may be responsible for complement activation. First, enzymatic degradation of LDL generates a derivative that can spontaneously activate complement, and enzymatically degraded LDL (E-LDL) has been detected in the lesions. Second, C-reactive protein (CRP) colocalizes with complement C5b-9, as evidenced by immunohistological studies of early atherosclerotic lesions, so the possibility exists that this acute phase protein also fulfills a…

PhosphorylcholineNeuraminidaseComplement Membrane Attack ComplexCoronary Artery DiseaseBiologyPhospholipaseLesionPathogenesismedicineHumansElectrophoresis Gel Two-DimensionalTrypsinComplement Activationchemistry.chemical_classificationPhosphorylcholineC-reactive proteinAcute-phase proteinCholesterol LDLComplement C3Coronary VesselsMolecular biologyComplement systemC-Reactive ProteinEnzymeBiochemistrychemistryType C Phospholipasesbiology.proteinCalciummedicine.symptomCardiology and Cardiovascular MedicineProtein BindingArteriosclerosis, Thrombosis, and Vascular Biology
researchProduct

Autoradiographic technique to assess distribution of blood flow within organs

1969

A method is described for assessing the distribution of blood flow within organs. Microspheres, 5–50 μ in diameter, labelled with a beta-emitting isotope were injected into the left ventricle of experimental animals. The distribution of the indicator within the tissues, which is assumed to represent the regional distribution of flow, was visualized and measured quantitatively by autoradiography. Local flow rates in areas of about 1,2 mm in diameter could be determined. Application of the technique for the study of regional myocardial and renal circulation is demonstrated.

PhysiologyClinical BiochemistryKidneyRadioactive microspheresMicrosphereDogsPhysiology (medical)MethodsmedicineAnimalsDistribution (pharmacology)Serum Albumin Radio-IodinatedRenal circulationIsotopeChemistryBrainBlood flowHuman physiologyAnatomyCoronary Vesselsmedicine.anatomical_structureRegional Blood FlowVentricleCatsAutoradiographyRabbitsPfl�gers Archiv European Journal of Physiology
researchProduct

Paraoxonase-2 Reduces Oxidative Stress in Vascular Cells and Decreases Endoplasmic Reticulum Stress–Induced Caspase Activation

2007

Background— In the vascular system, elevated levels of reactive oxygen species (ROS) produce oxidative stress and predispose to the development of atherosclerosis. Therefore, it is important to understand the systems producing and those scavenging vascular ROS. Here, we analyzed the ROS-reducing capability of paraoxonase-2 (PON2) in different vascular cells and its involvement in the endoplasmic reticulum stress pathway known as the unfolded protein response. Methods and Results— Quantitative real-time polymerase chain reaction and Western blotting revealed that PON2 is equally expressed in vascular cells and appears in 2 distinct glycosylated isoforms. By determining intracellular ROS, we…

Protein FoldingNuclear EnvelopeRecombinant Fusion ProteinsEndoplasmic Reticulummedicine.disease_causeMuscle Smooth VascularPhysiology (medical)medicineHumansNuclear membraneCells CulturedCaspaseEndoplasmchemistry.chemical_classificationReactive oxygen speciesbiologyAryldialkylphosphataseEndoplasmic reticulumGene Transfer TechniquesEndothelial CellsFibroblastsCoronary VesselsCell biologyEnzyme ActivationOxidative Stressmedicine.anatomical_structurechemistryBiochemistryCaspasesUnfolded protein responsebiology.proteinReactive Oxygen SpeciesCardiology and Cardiovascular MedicineIntracellularOxidative stressSignal TransductionCirculation
researchProduct

Feasibility of transcatheter aortic valve implantation in patients with coronary heights ≤7 mm: insights from the transcatheter aortic valve implanta…

2018

OBJECTIVES Transcatheter aortic valve implantation (TAVI) in patients with low coronary heights is generally denied but is not impossible. Information about these high-risk procedures is sparse. METHODS Since May 2008, data of more than 3000 patients who had TAVI were prospectively collected in the institutional TAVI Karlsruhe registry. Characteristics, peri- and postoperative outcome of patients with low coronary heights of ≤7 mm were analysed according to the Valve Academic Research Consortium-2. RESULTS Eighty-six patients with an average coronary height of 6.4 ± 1.1 mm (mean age 81.0 ± 5.3 years, logistic EuroSCORE I 19.6 ± 13.3%) were treated. TAVI was performed in 72 transfemoral (83.…

Pulmonary and Respiratory MedicineMalemedicine.medical_specialtymedicine.medical_treatment030204 cardiovascular system & hematologyCoronary AngiographyTranscatheter Aortic Valve Replacement03 medical and health sciences0302 clinical medicinePostoperative ComplicationsValve replacementGermanyMedicineHumans030212 general & internal medicineProspective StudiesRegistriesProspective cohort studyAortic dissectionAged 80 and overBioprosthesisbusiness.industryMortality rateIncidenceHazard ratioExtracorporeal circulationPercutaneous coronary interventionGeneral MedicineAortic Valve Stenosismedicine.diseaseCoronary VesselsSurgerySurvival RateTreatment OutcomeCoronary OcclusionCoronary occlusionAortic ValveFluoroscopyFeasibility StudiesSurgeryFemaleCardiology and Cardiovascular MedicinebusinessFollow-Up StudiesEuropean journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery
researchProduct

Relaxation induced by cGMP phosphodiesterase inhibitors sildenafil and zaprinast in human vessels

2000

Abstract Background . Sildenafil is currently used in the treatment of erectile dysfunction. However, assessment of direct effects of sildenafil on coronary arteries and on arteries used as coronary grafts is unknown. This study was designed to investigate the effects of sildenafil on contracted human coronary, internal mammary, and radial arteries obtained from multiorgan donors. The observations were extended to forearm veins. Zaprinast was included in this study for comparison. Methods . Segments of left coronary, internal mammary, and radial arteries, and forearm veins were obtained from 16 multiorgan donors. Vascular rings were suspended in organ bath chambers and isometric tension was…

Pulmonary and Respiratory Medicinemedicine.medical_specialtyPurinonesPhosphodiesterase InhibitorsSildenafilMuscle Smooth VascularPiperazinesSildenafil CitrateVeinschemistry.chemical_compound3'5'-Cyclic-GMP Phosphodiesterasesmedicine.arteryInternal medicinemedicineHumansSulfonesMammary ArteriesRadial arteryVeinDose-Response Relationship Drugbusiness.industryPhosphodiesteraseCoronary VesselsPDE5 drug designrespiratory tract diseasesVasodilationCoronary arteriesmedicine.anatomical_structurechemistryPurinesAnesthesiaRadial Arterycardiovascular systemCardiologySurgerySodium nitroprussideCardiology and Cardiovascular MedicinebusinessZaprinastmedicine.drugThe Annals of Thoracic Surgery
researchProduct

Rational and design of the European randomized Optical Coherence Tomography Optimized Bifurcation Event Reduction Trial (OCTOBER)

2018

Background Percutaneous coronary intervention in complex bifurcation lesions is prone to suboptimal implantation results and is associated with increased risk of subsequent clinical events. Angiographic ambiguity is high during bifurcation stenting, but it is unknown if procedural guidance by intravascular optical coherence tomography (OCT) improves clinical outcome. Methods and design OCTOBER is a randomized, investigator-initiated, multicenter trial aimed to show superiority of OCT-guided stent implantation compared to standard angiographic-guided implantation in bifurcation lesions. The primary outcome measure is a 2-year composite end point of cardiac death, target lesion myocardial inf…

Target lesionMalemedicine.medical_specialtyBiolääketieteet - Biomedicinemedicine.medical_treatment030204 cardiovascular system & hematologyCoronary AngiographyLesion03 medical and health sciences0302 clinical medicinePercutaneous Coronary InterventionMulticenter trialmedicineHumans030212 general & internal medicineMyocardial infarctionTomographyAgedUnstable anginabusiness.industrySisätaudit - Internal medicineCoronary StenosisPercutaneous coronary interventionStentDrug-Eluting StentsMiddle Agedmedicine.diseaseCoronary VesselsStenosisTreatment OutcomeOptical CoherenceSettore MED/11 - MALATTIE DELL'APPARATO CARDIOVASCOLAREFemaleRadiologymedicine.symptomCardiology and Cardiovascular MedicinebusinessTomography Optical CoherenceAmerican Heart Journal
researchProduct

Impact of coronary calcification on outcomes after ABSORB scaffold implantation: insights from the GABI-R registry.

2020

OBJECTIVE To investigate the outcomes after bioresorbable scaffold (BRS) implantation in calcified coronary lesions. In calcified coronary lesions, durable metallic drug-eluting stent (DES) implantation is associated with worse clinical outcomes compared to noncalcified lesions. Although not recommended, BRSs were frequently implanted in calcified lesions in clinical practice. Their outcome is not well investigated. METHODS Between November 2013 and January 2016, 3326 patients were enrolled in the German-Austrian ABSORB ReglstRy (GABI-R). Lesion calcification severity was classified into no (n = 1144), mild (n = 1306), and moderate-to-severe (n = 690) calcification. RESULTS Patients with ca…

Target lesionMalemedicine.medical_specialtymedicine.medical_treatmentMyocardial InfarctionLong Term Adverse EffectsCoronary Artery Disease030204 cardiovascular system & hematologySeverity of Illness IndexLesion03 medical and health sciences0302 clinical medicinePercutaneous Coronary InterventionPostoperative ComplicationsInternal medicineDiabetes mellitusAbsorbable ImplantsmedicineHumans030212 general & internal medicineMyocardial infarctionRegistriesVascular CalcificationVascular PatencyTissue Scaffoldsbusiness.industryIncidence (epidemiology)StentDrug-Eluting StentsGeneral MedicineMiddle Agedmedicine.diseaseThrombosisCoronary VesselsCardiologyFemalemedicine.symptomCardiology and Cardiovascular MedicinebusinessCalcificationCoronary artery disease
researchProduct